Pulse Biosciences Unveils Promising First-in-Human Data for nPulse

Key Takeaways PLSE reports encouraging feasibility results for its nPulse Cardiac Surgical System using nsPFA.PLSE study achieved 94% pulmonary vein and 100% posterior box isolation success with no major complications.An IDE study in the U.S. is planned, advancing PLSE toward regulatory approval and commercialization.Pulse Biosciences (PLSE) recently reported encouraging late-breaking data from the first-in-human feasibility study of its nPulse Cardiac Surgical System. The study data were unveiled at the 39 ...